Skip to main content
. 2014 Aug 2;7(5):442–449. doi: 10.1093/ckj/sfu080

Table 1.

Dosing and pharmacological characteristics of three low-molecular weight heparins in chronic kidney disease

Dalteparin [26] Enoxaparin [27] Tinzaparin [28]
Treatment indications (dose) ACS (120 IU/kg BD), VTE (200 IU/kg OD) ACS (1 mg/kg BD), VTE (1.5 mg/kg OD) VTE (175 IU/kg OD)
Dosing advice in CKD 4/5 No dose adjustment advised except with anti-Xa level for eGFR <30 mL/min Dose reduction to 1 mg/kg once daily if eGFR <30 mL/min No dose reduction needed if eGFR >20 mL/min.
Dose adjust as per anti-Xa level if <20 mL/min
Anti-Xa:IIa ratio 2.2 3.9 2.8
Average molecular weight (Da) 5000 4500 5500–7500

OD, once daily; BD, twice daily; VTE, venous thromboembolism.